DE60223340D1 - Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung - Google Patents
Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendungInfo
- Publication number
- DE60223340D1 DE60223340D1 DE60223340T DE60223340T DE60223340D1 DE 60223340 D1 DE60223340 D1 DE 60223340D1 DE 60223340 T DE60223340 T DE 60223340T DE 60223340 T DE60223340 T DE 60223340T DE 60223340 D1 DE60223340 D1 DE 60223340D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv infection
- treatment
- serpine
- drugs
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26433801P | 2001-01-26 | 2001-01-26 | |
US264338P | 2001-01-26 | ||
PCT/US2002/002309 WO2002058638A2 (en) | 2001-01-26 | 2002-01-25 | Serpin drugs for treatment of hiv infection and method of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60223340D1 true DE60223340D1 (de) | 2007-12-20 |
DE60223340T2 DE60223340T2 (de) | 2008-08-28 |
Family
ID=23005599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60223340T Expired - Lifetime DE60223340T2 (de) | 2001-01-26 | 2002-01-25 | Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020127698A1 (de) |
EP (1) | EP1362127B1 (de) |
AT (1) | ATE377657T1 (de) |
AU (1) | AU2002248384A1 (de) |
DE (1) | DE60223340T2 (de) |
ES (1) | ES2296914T3 (de) |
WO (1) | WO2002058638A2 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10045047A1 (de) * | 2000-09-12 | 2002-03-21 | Beate Kehrel | Arzneimittel enthaltend aktiviertes Antithrombin III |
US20110008889A1 (en) * | 2001-01-26 | 2011-01-13 | Ralf Geiben-Lynn | Serpin drugs for treatment of hiv infection and method of use thereof |
US7326692B2 (en) * | 2001-11-14 | 2008-02-05 | The University Of Chicago | Induction of immunity using inhibitors of granzymes |
US7218948B2 (en) * | 2003-02-24 | 2007-05-15 | Qualcomm Incorporated | Method of transmitting pilot tones in a multi-sector cell, including null pilot tones, for generating channel quality indicators |
US9661519B2 (en) | 2003-02-24 | 2017-05-23 | Qualcomm Incorporated | Efficient reporting of information in a wireless communication system |
US8811348B2 (en) * | 2003-02-24 | 2014-08-19 | Qualcomm Incorporated | Methods and apparatus for generating, communicating, and/or using information relating to self-noise |
US9544860B2 (en) * | 2003-02-24 | 2017-01-10 | Qualcomm Incorporated | Pilot signals for use in multi-sector cells |
US7498130B2 (en) | 2003-05-13 | 2009-03-03 | Massachusetts General Hospital | Method of reducing viral load |
US20040229778A1 (en) * | 2003-05-13 | 2004-11-18 | Elmaleh David R. | Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
JP2008505912A (ja) * | 2004-07-07 | 2008-02-28 | ザ ジェネラル ホスピタル コーポレーション | 全血及び血漿におけるatiiiの直接的活性化法 |
US8503938B2 (en) * | 2004-10-14 | 2013-08-06 | Qualcomm Incorporated | Methods and apparatus for determining, communicating and using information including loading factors which can be used for interference control purposes |
US20060092881A1 (en) * | 2004-10-14 | 2006-05-04 | Rajiv Laroia | Methods and apparatus for determining, communicating and using information which can be used for interference control purposes |
KR100911087B1 (ko) * | 2004-10-14 | 2009-08-06 | 콸콤 인코포레이티드 | 간섭 제어 목적으로 사용될 수 있는 정보를 결정, 통신, 및사용하기 위한 방법 및 장치 |
ES2565543T3 (es) * | 2005-01-24 | 2016-04-05 | Board Of Regents, The University Of Texas System | Construcciones de fusión a Fc de unión a fosfatidilserina y su uso terapéutico |
US9191840B2 (en) * | 2005-10-14 | 2015-11-17 | Qualcomm Incorporated | Methods and apparatus for determining, communicating and using information which can be used for interference control |
US8694042B2 (en) | 2005-10-14 | 2014-04-08 | Qualcomm Incorporated | Method and apparatus for determining a base station's transmission power budget |
US20090227518A1 (en) * | 2005-12-02 | 2009-09-10 | The Regents Of The University Of Colorado | Compositions and methods for treating actin-mediated medical conditions |
US9125093B2 (en) * | 2005-12-22 | 2015-09-01 | Qualcomm Incorporated | Methods and apparatus related to custom control channel reporting formats |
US9119220B2 (en) * | 2005-12-22 | 2015-08-25 | Qualcomm Incorporated | Methods and apparatus for communicating backlog related information |
US20070253449A1 (en) * | 2005-12-22 | 2007-11-01 | Arnab Das | Methods and apparatus related to determining, communicating, and/or using delay information |
US9572179B2 (en) | 2005-12-22 | 2017-02-14 | Qualcomm Incorporated | Methods and apparatus for communicating transmission backlog information |
US9148795B2 (en) * | 2005-12-22 | 2015-09-29 | Qualcomm Incorporated | Methods and apparatus for flexible reporting of control information |
US20070149132A1 (en) | 2005-12-22 | 2007-06-28 | Junyl Li | Methods and apparatus related to selecting control channel reporting formats |
US9451491B2 (en) * | 2005-12-22 | 2016-09-20 | Qualcomm Incorporated | Methods and apparatus relating to generating and transmitting initial and additional control information report sets in a wireless system |
US9473265B2 (en) | 2005-12-22 | 2016-10-18 | Qualcomm Incorporated | Methods and apparatus for communicating information utilizing a plurality of dictionaries |
US9125092B2 (en) | 2005-12-22 | 2015-09-01 | Qualcomm Incorporated | Methods and apparatus for reporting and/or using control information |
US8437251B2 (en) | 2005-12-22 | 2013-05-07 | Qualcomm Incorporated | Methods and apparatus for communicating transmission backlog information |
US9338767B2 (en) * | 2005-12-22 | 2016-05-10 | Qualcomm Incorporated | Methods and apparatus of implementing and/or using a dedicated control channel |
US9137072B2 (en) | 2005-12-22 | 2015-09-15 | Qualcomm Incorporated | Methods and apparatus for communicating control information |
US8514771B2 (en) * | 2005-12-22 | 2013-08-20 | Qualcomm Incorporated | Methods and apparatus for communicating and/or using transmission power information |
US20070243882A1 (en) * | 2006-04-12 | 2007-10-18 | Qualcomm Incorporated | Method and apparatus for locating a wireless local area network associated with a wireless wide area network |
RU2013113723A (ru) * | 2010-09-14 | 2014-10-20 | Ф.Хоффманн-Ля Рош Аг | Гибридный полипептид с серпиновым "пальцем" |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE392038B (sv) * | 1971-09-08 | 1977-03-14 | Kabi Ab | Forfarande for isolering av antitrombin ur blod eller blodprodukter |
JPS597693B2 (ja) * | 1978-01-07 | 1984-02-20 | 株式会社ミドリ十字 | 抗トロンビン製剤及びその製法 |
DE3170001D1 (en) * | 1980-09-30 | 1985-05-23 | Bayer Ag | Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex |
EP0090505B1 (de) | 1982-03-03 | 1990-08-08 | Genentech, Inc. | Menschliches Antithrombin III, DNS Sequenzen dafür, Expressions- und Klonierungsvektoren die solche Sequenzen enthalten und damit transformierte Zellkulturen, Verfahren zur Expression von Menschlichem Antithrombin III und diese enthaltende pharmazeutische Zusammensetzungen |
US4689323A (en) * | 1983-09-26 | 1987-08-25 | Miles Laboratories, Inc. | Covalently bound heparin--antithrombin-III complex |
CA1341379C (en) | 1988-04-28 | 2002-07-23 | Welfide Corporation | Purified antithrombin-iii and methods of producing the same |
US5610286A (en) | 1991-11-04 | 1997-03-11 | The Regents Of The University Of California | DNA's encoding natural killer cell enhancing factor |
US5376633A (en) * | 1992-09-30 | 1994-12-27 | Lezdey; John | Method for deactivating viruses in blood component containers |
WO1996010638A1 (en) | 1994-09-30 | 1996-04-11 | Ppl Therapeutics (Scotland) Ltd. | Alpha-1-antitrypsin and antithrombine-iii variants |
WO1996039424A1 (en) | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Natural killer cell enhancing factor c |
AU3719100A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
-
2002
- 2002-01-25 AU AU2002248384A patent/AU2002248384A1/en not_active Abandoned
- 2002-01-25 AT AT02717374T patent/ATE377657T1/de not_active IP Right Cessation
- 2002-01-25 US US10/057,613 patent/US20020127698A1/en not_active Abandoned
- 2002-01-25 ES ES02717374T patent/ES2296914T3/es not_active Expired - Lifetime
- 2002-01-25 DE DE60223340T patent/DE60223340T2/de not_active Expired - Lifetime
- 2002-01-25 WO PCT/US2002/002309 patent/WO2002058638A2/en active IP Right Grant
- 2002-01-25 EP EP02717374A patent/EP1362127B1/de not_active Expired - Lifetime
-
2004
- 2004-07-15 US US10/892,676 patent/US7510828B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002058638A2 (en) | 2002-08-01 |
US7510828B2 (en) | 2009-03-31 |
EP1362127A4 (de) | 2004-09-22 |
DE60223340T2 (de) | 2008-08-28 |
US20020127698A1 (en) | 2002-09-12 |
EP1362127A2 (de) | 2003-11-19 |
EP1362127B1 (de) | 2007-11-07 |
WO2002058638A3 (en) | 2002-09-26 |
US20050058637A1 (en) | 2005-03-17 |
ES2296914T3 (es) | 2008-05-01 |
ATE377657T1 (de) | 2007-11-15 |
AU2002248384A1 (en) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60223340D1 (de) | Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung | |
DE60229059D1 (de) | Proteomimetische verbindungen und verfahren | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
ATE463294T1 (de) | Verfahren zur konzentration und reinigung von biologischen verbindungen | |
ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
ATE404587T1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
HUP0401590A2 (hu) | Eljárások allogén sziget átültetés védelmére oldható CTLA4 mutáns molekulák alkalmazásával | |
DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
DE69414700D1 (de) | Parvovirusrezeptoren und verfahren zur ihrer verwendung | |
DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
ATE326466T1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
DE112004000961D2 (de) | Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen | |
ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
DE60136381D1 (de) | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität | |
ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
DE602004028574D1 (de) | Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie | |
MA27474A1 (fr) | Vaccin | |
DE69429856D1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
DE60231475D1 (de) | Materialien und methoden zur behandlung von hepatitis c | |
ATE286487T1 (de) | Verfahren zur reinigung von wasser, dafür geeignete bakterien und deren verwendung | |
DE602005027228D1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind | |
DE60013326D1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
ATE532509T1 (de) | Mittel zur hemmung des eintritts des hiv-virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |